Syneos Health Inc. Shareholder Investigation Submission Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of SYNH. As a result of the merger, SYNH stockholders are anticipated to receive only $43.00 per share in cash, well below the 52-week high of $79.77 per share. The SYNH merger investigation concerns whether the Board of SYNH has harmed stockholders by agreeing to enter into the transaction with a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital, and whether all material facts have been properly disclosed to stockholders.